119 related articles for article (PubMed ID: 35345262)
1. Aortic Root Dilatation in Hypertensive Patients with Left Ventricular Hypertrophy-Application of A New Multivariate Predictive Model. The Life Study.
Lilja-Cyron A; Bang CN; Gerdts E; Larstorp AC; Kjeldsen SE; Julius S; Okin PM; Wachtell K; Devereux RB
Rev Cardiovasc Med; 2022 Mar; 23(3):95. PubMed ID: 35345262
[TBL] [Abstract][Full Text] [Related]
2. Sex-specific hemodynamic and non-hemodynamic determinants of aortic root size in hypertensive subjects with left ventricular hypertrophy.
Cipolli JA; Souza FA; Ferreira-Sae MC; Pio-Magalhães JA; Figueiredo ES; Vidotti VG; Matos-Souza JR; Franchini KG; Nadruz W
Hypertens Res; 2009 Nov; 32(11):956-61. PubMed ID: 19713970
[TBL] [Abstract][Full Text] [Related]
3. Aortic root dilatation at sinuses of valsalva and aortic regurgitation in hypertensive and normotensive subjects: The Hypertension Genetic Epidemiology Network Study .
Palmieri V; Bella JN; Arnett DK; Roman MJ; Oberman A; Kitzman DW; Hopkins PN; Paranicas M; Rao DC; Devereux RB
Hypertension; 2001 May; 37(5):1229-35. PubMed ID: 11358933
[TBL] [Abstract][Full Text] [Related]
4. Four-group classification of left ventricular hypertrophy based on ventricular concentricity and dilatation identifies a low-risk subset of eccentric hypertrophy in hypertensive patients.
Bang CN; Gerdts E; Aurigemma GP; Boman K; de Simone G; Dahlöf B; Køber L; Wachtell K; Devereux RB
Circ Cardiovasc Imaging; 2014 May; 7(3):422-9. PubMed ID: 24723582
[TBL] [Abstract][Full Text] [Related]
5. Aortic root dilatation in hypertensive patients: a multicenter survey in echocardiographic practice.
Cuspidi C; Negri F; Salvetti M; Lonati L; Sala C; Capra A; Milan A; Danzi GB; Morganti A;
Blood Press; 2011 Oct; 20(5):267-73. PubMed ID: 21388253
[TBL] [Abstract][Full Text] [Related]
6. Systolic left ventricular function according to left ventricular concentricity and dilatation in hypertensive patients: the Losartan Intervention For Endpoint reduction in hypertension study.
Bang CN; Gerdts E; Aurigemma GP; Boman K; Dahlöf B; Roman MJ; Køber L; Wachtell K; Devereux RB
J Hypertens; 2013 Oct; 31(10):2060-8. PubMed ID: 23838656
[TBL] [Abstract][Full Text] [Related]
7. Correlates of left atrial size in hypertensive patients with left ventricular hypertrophy: the Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) Study.
Gerdts E; Oikarinen L; Palmieri V; Otterstad JE; Wachtell K; Boman K; Dahlöf B; Devereux RB;
Hypertension; 2002 Mar; 39(3):739-43. PubMed ID: 11897755
[TBL] [Abstract][Full Text] [Related]
8. Impact of valvular regurgitation on left ventricular geometry and function in hypertensive patients with left ventricular hypertrophy: the LIFE study.
Kontos J; Papademetriou V; Wachtell K; Palmieri V; Liu JE; Gerdts E; Boman K; Nieminen MS; Dahlöf B; Devereux RB
J Hum Hypertens; 2004 Jun; 18(6):431-6. PubMed ID: 15042117
[TBL] [Abstract][Full Text] [Related]
9. Aortic Root Dilatation Is Associated With Incident Cardiovascular Events in a Population of Treated Hypertensive Patients: The Campania Salute Network.
Canciello G; Mancusi C; Losi MA; Izzo R; Trimarco B; de Simone G; De Luca N
Am J Hypertens; 2018 Nov; 31(12):1317-1323. PubMed ID: 30099532
[TBL] [Abstract][Full Text] [Related]
10. Association of left ventricular dilatation and hypertrophy with chronotropic incompetence in the Framingham Heart Study.
Lauer MS; Larson MG; Evans JC; Levy D
Am Heart J; 1999 May; 137(5):903-9. PubMed ID: 10220640
[TBL] [Abstract][Full Text] [Related]
11. Association of pulse pressure with new-onset atrial fibrillation in patients with hypertension and left ventricular hypertrophy: the Losartan Intervention For Endpoint (LIFE) reduction in hypertension study.
Larstorp AC; Ariansen I; Gjesdal K; Olsen MH; Ibsen H; Devereux RB; Okin PM; Dahlöf B; Kjeldsen SE; Wachtell K
Hypertension; 2012 Aug; 60(2):347-53. PubMed ID: 22753219
[TBL] [Abstract][Full Text] [Related]
12. Gender differences in left ventricular structure and function during antihypertensive treatment: the Losartan Intervention for Endpoint Reduction in Hypertension Study.
Gerdts E; Okin PM; de Simone G; Cramariuc D; Wachtell K; Boman K; Devereux RB
Hypertension; 2008 Apr; 51(4):1109-14. PubMed ID: 18259011
[TBL] [Abstract][Full Text] [Related]
13. Left atrial size and risk of major cardiovascular events during antihypertensive treatment: losartan intervention for endpoint reduction in hypertension trial.
Gerdts E; Wachtell K; Omvik P; Otterstad JE; Oikarinen L; Boman K; Dahlöf B; Devereux RB
Hypertension; 2007 Feb; 49(2):311-6. PubMed ID: 17178978
[TBL] [Abstract][Full Text] [Related]
14. Aortic root dilatation in the children and young adults: prevalence, determinants, and association with target organ damage.
Totaro S; Rabbia F; Milan A; Urbina EM; Veglio F
J Am Soc Hypertens; 2016 Oct; 10(10):782-789. PubMed ID: 27637377
[TBL] [Abstract][Full Text] [Related]
15. Ascending aortic dilatation, arterial stiffness and cardiac organ damage in essential hypertension.
Milan A; Tosello F; Naso D; Avenatti E; Leone D; Magnino C; Veglio F
J Hypertens; 2013 Jan; 31(1):109-16. PubMed ID: 23221933
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and correlates of aortic root dilatation in patients with essential hypertension: relationship with cardiac and extracardiac target organ damage.
Cuspidi C; Meani S; Fusi V; Valerio C; Sala C; Zanchetti A
J Hypertens; 2006 Mar; 24(3):573-80. PubMed ID: 16467661
[TBL] [Abstract][Full Text] [Related]
17. Two-dimensional echocardiographic aortic root dimensions in normal children and adults.
Roman MJ; Devereux RB; Kramer-Fox R; O'Loughlin J
Am J Cardiol; 1989 Sep; 64(8):507-12. PubMed ID: 2773795
[TBL] [Abstract][Full Text] [Related]
18. [Prevalence of the proximal aortic root dilatation and it relationship with left ventricular remodelling among South-Kivu Congolese patients: A cross sectional study].
Katchunga P; Kaishusha D; Mwambusa R; Mubalama E
Ann Cardiol Angeiol (Paris); 2018 Sep; 67(4):250-255. PubMed ID: 29909952
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and correlates of left atrial enlargement in essential hypertension: role of ventricular geometry and the metabolic syndrome: the Evaluation of Target Organ Damage in Hypertension study.
Cuspidi C; Meani S; Fusi V; Valerio C; Catini E; Sala C; Sampieri L; Magrini F; Zanchetti A
J Hypertens; 2005 Apr; 23(4):875-82. PubMed ID: 15775794
[TBL] [Abstract][Full Text] [Related]
20. Aortic root dilatation as a cause of isolated, severe aortic regurgitation. Prevalence, clinical and echocardiographic patterns, and relation to left ventricular hypertrophy and function.
Roman MJ; Devereux RB; Niles NW; Hochreiter C; Kligfield P; Sato N; Spitzer MC; Borer JS
Ann Intern Med; 1987 Jun; 106(6):800-7. PubMed ID: 2953289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
